Modi will come back to power, says his brother in Mangaluru

Mangaluru,  May 3: An unidentified vehicle mowed down a 62-year-old security guard near Guruvayanakere, Belthangady taluk, on Saturday.

The deceased Lingappa Moolya was returning to his home in Guruvayanakere on a two-wheeler when the hit-and-run case took place. Police said he was hit by a truck. A guard at an ATM, Moolya was also an active member of the local Kulala Association.

A case was registered at Belthangady police station.

Bengaluru, Apr 13: Fifteen new positive cases of coronavirus have been confirmed in Karnataka, taking the total number of affected in the state to 247, the Health department said on Monday.

"Fifteen new positive cases have been reported from last evening to this noon.... Till date 247 COVID-19 positive cases have been confirmed. This includes 6 deaths and 59 discharges," the department said in a mid-day situation report.

Among the 15 new cases thirteen are contacts of patients already tested positive, while one from Dodabballapura in Bengaluru Rural is with a travel history to Delhi, the other from Bengaluru city has Severe Acute Respiratory Infection (SARI).

Among the 13 contact cases tested positive four are from Hubballi in Dharwad district, three each from Malavalli in Mandya district and Raibag in Belagavi, two each from Bidar, and one from Mudhol in Bagalkote district.

Three out of 15 new cases are children- a 8 year-old girl from Malavalli in Mandya, 16-year old girl from Bidar and 14-year old boy from Raibag in Belagavi.

From across the state most number of infections have been reported in Bengaluru with 77, followed by Mysuru (48) and Belagavi (17).

Those discharged include 27 patients from Bengaluru, nine from Mysuru, seven from Dakshina Kannada, six from Chikkaballapura, three from Davangere, two each from Uttara Kannada and Kalaburagi, and one each from Udupi, Dharwad and Kodagu.

Among the dead, two are from Kalaburagi and one each from Bengaluru, Bagalkote, Gadag and Tumakuru.

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.